RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Abbott Laboratories P/E 2024

Abbott Laboratories P/E

23.21

Abbott Laboratories Dividend yield

1.91 %

Ticker

ABT

ISIN

US0028241000

WKN

850103

As of Apr 27, 2024, Abbott Laboratories's P/E ratio was 23.21, a -26.13% change from the 31.42 P/E ratio recorded in the previous year.

The Abbott Laboratories P/E history

Abbott Laboratories Aktienanalyse

What does Abbott Laboratories do?

Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Abbott Laboratories's P/E Ratio

The Price to Earnings (P/E) Ratio of Abbott Laboratories is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Abbott Laboratories's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Abbott Laboratories is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Abbott Laboratories’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Abbott Laboratories Stock

What is the price-to-earnings ratio of Abbott Laboratories?

The price-earnings ratio of Abbott Laboratories is currently 23.21.

How has the price-earnings ratio of Abbott Laboratories changed compared to last year?

The price-to-earnings ratio of Abbott Laboratories has increased by -26.13% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Abbott Laboratories high compared to other companies?

Yes, the price-to-earnings ratio of Abbott Laboratories is high compared to other companies.

How does an increase in the price-earnings ratio of Abbott Laboratories affect the company?

An increase in the price-earnings ratio of Abbott Laboratories would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Abbott Laboratories affect the company?

A decrease in the price-earnings ratio of Abbott Laboratories would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Abbott Laboratories?

Some factors that influence the price-earnings ratio of Abbott Laboratories are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Abbott Laboratories pay?

Over the past 12 months, Abbott Laboratories paid a dividend of 2.04 USD . This corresponds to a dividend yield of about 1.91 %. For the coming 12 months, Abbott Laboratories is expected to pay a dividend of 2.24 USD.

What is the dividend yield of Abbott Laboratories?

The current dividend yield of Abbott Laboratories is 1.91 %.

When does Abbott Laboratories pay dividends?

Abbott Laboratories pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Abbott Laboratories?

Abbott Laboratories paid dividends every year for the past 25 years.

What is the dividend of Abbott Laboratories?

For the upcoming 12 months, dividends amounting to 2.24 USD are expected. This corresponds to a dividend yield of 2.09 %.

In which sector is Abbott Laboratories located?

Abbott Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbott Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbott Laboratories from 5/15/2024 amounting to 0.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.

When did Abbott Laboratories pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Abbott Laboratories in the year 2023?

In the year 2023, Abbott Laboratories distributed 1.88 USD as dividends.

In which currency does Abbott Laboratories pay out the dividend?

The dividends of Abbott Laboratories are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Abbott Laboratories stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Abbott Laboratories

Our stock analysis for Abbott Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.